Advarra Educational Resources

• Informed Consent: When, Why, and How It’s Obtained
• Q&A: Institutional Responsibilities Under a Federalwide Assurance
• Understanding the Complexity and Uniqueness of Phase I Trials
• Q&A – Regulatory Fine Points: Exploring 21 CFR Part 11 Validation
• Utilizing eRegulatory Integrations to Expedite Regulatory Workflows
• mRNA and Its Role in Clinical Research